Date :
Place : United States of America, Boston
Website :http://go.evvnt.com/2695554-0?pid=80
Contact Person:Lauren Thursby
Description:
Translating Induced Proximity, AutoTAC, PROTAC and Other TPDs Into the Clinic to Target Neurodegeneration and Neuro-Oncology. Time: 9:00 AM - 5:00 PM. Prices: USD 2599.00 - USD 5097.00.Deadline for abstracts/proposals : 18th February 2025
Organized By :
Keynote Speakers :
Conference Highlights :Home | Protein Degradation for CNS
The Protein Degradation for CNS Summit is uniting 50+ experts with 3-days of industry-focused content solely dedicated to delivering & translating TPD technologies to degrade undruggable extracellular & intracellular CNS proteins.
Translating Induced Proximity,AutoTAC, PROTAC & Other TPDs Into the Clinic to Target Neurodegeneration & Neuro-Oncology
With this ever-progressing field in neurodegenerative disease drug development, the design of protein degradation therapies has gained huge amounts of momentum. With the first patient dosed by Arvinas, the movement towards clinic has rapidly changed the focus of the field towards translating towards Phase I trials.
Be a part of the future of protein degradation for CNS diseases by keeping your knowledge up-to-date at the2nd Protein Degradation for CNSSummit, returning to Boston for its 2nd year running. Hear the latest findings in degrader design, target identification, mechanism selection and PKPD considerations at this industry-leading conference, with expert speakers fromArvinas, BiogenandMonte Rosa Therapeutics.
Chief Technology Officer / Research Assistant Professor
Check the event website for more details.